Anavex Life Sciences Corp (AVXL)

[Investor2014]

IMO still after today much more likely a P3 Precision Medicine trial with A2-73 next in AD, than Accelerated approval - unfortunately.

Obviously no discussions with the FDA or others until that deep analysis is done. I give a 5% chance that regulators will accept SIGMAR1 mRNA expression and whatever other correlated biomarkers are found from the deep analysis for AA.